Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Holzer, Timothy R.
Man, Michael Z.
Schade, Andrew E.
Funding for this research was provided by:
Eli Lilly & Co